The store will not work correctly when cookies are disabled.
5-Phenyl-3-(4-(5-phenyl-1,4,2-dioxazol-3-yl)phenyl)-1,4,2-dioxazole
ID: ALA1080967
PubChem CID: 44516438
Max Phase: Preclinical
Molecular Formula: C22H16N2O4
Molecular Weight: 372.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: c1ccc(C2ON=C(c3ccc(C4=NOC(c5ccccc5)O4)cc3)O2)cc1
Standard InChI: InChI=1S/C22H16N2O4/c1-3-7-17(8-4-1)21-25-19(23-27-21)15-11-13-16(14-12-15)20-24-28-22(26-20)18-9-5-2-6-10-18/h1-14,21-22H
Standard InChI Key: HSFOIUZEWJQHSN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
12.9973 -1.2841 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1727 -1.2606 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9415 -0.4687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6238 -0.0052 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2745 -0.5108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2244 -0.0622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5113 -0.4764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7938 -0.0657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7895 0.7593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5026 1.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2200 0.7628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3360 2.3246 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.1209 2.0668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1209 1.2418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3360 0.9881 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8535 1.6564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0284 1.6564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6137 0.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7887 0.9413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3783 1.6564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7887 2.3715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6137 2.3715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9960 -0.1107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0119 0.7158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7335 1.1160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4392 0.6896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4249 -0.1312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7034 -0.5314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
1 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
6 11 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
12 16 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
17 22 2 0
16 17 1 0
9 14 1 0
3 6 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
23 28 2 0
5 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.38 | Molecular Weight (Monoisotopic): 372.1110 | AlogP: 4.50 | #Rotatable Bonds: 4 |
Polar Surface Area: 61.64 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.97 | CX LogP: 6.05 | CX LogD: 6.05 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.68 | Np Likeness Score: -0.10 |
References
1. Iqbal PF, Parveen H, Bhat AR, Hayat F, Azam A.. (2009) Synthesis, characterization, antiamoebic activity and toxicity of novel bisdioxazole derivatives., 44 (11): [PMID:19589625] [10.1016/j.ejmech.2009.06.016] |